Identification of SCARA5 as a potential biomarker for oral squamous cell carcinoma using MALDI TOF MS analysis

Conclusions and clinical relevanceScara5 has the potential to be considered as a serum biomarker in the early diagnosis of OSCC. The clinical relevance of the study lies in finding the biomarker by proteomics and subsequently validating it with clinical samples and cell lines.This article is protected by copyright. All rights reserved

Source: Proteomics. Clinical Applications - January 1, 2018 Category: Biochemistry Authors: Ying Liu, Yi ‐ran Tan, Wen‐wen Sun, Wu‐tong Ju, Yong Fu, Li‐zhen Wang, Jiang Li, Chen‐ping Zhang, Zhi‐yuan Zhang, Lai‐ping Zhong Tags: Research Article Source Type: research